Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The influenza A virus
NEP
(NS2) protein is an structural component of the viral particle. To investigate whether this protein has an effect on viral RNA synthesis, we examined the expression of an influenza A virus-like
chloramphenicol acetyltransferase
(
CAT
) RNA in cells synthesizing the four influenza A virus core proteins (nucleoprotein, PB1, PB2, and PA) and
NEP
from recombinant plasmids. Influenza A virus
NEP
inhibited drastically, and in a dose-dependent manner, the level of
CAT
expression mediated by the recombinant influenza A virus polymerase. This inhibitory effect was not observed in an analogous artificial system in which expression of a synthetic
CAT
RNA is mediated by the core proteins of an influenza B virus. This result ruled out the possibility that inhibition of reporter gene expression was due to a general toxic effect induced by
NEP
. Analysis of the virus-specific RNA species that accumulated in cells expressing the type A recombinant core proteins and
NEP
showed that there was an important reduction in the levels of minireplicon-derived vRNA, cRNA, and mRNA molecules. Taken together, the results obtained suggest a regulatory role for
NEP
during virus-specific RNA synthesis, and this finding is discussed regarding the biological implications for the virus life cycle.
...
PMID:Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs. 1131 64
Nucleocytoplasmic transport of viral ribonucleoproteins (vRNPs) is an essential aspect of the replication cycle for influenza A, B, and C viruses. These viruses replicate and transcribe their genomes in the nuclei of infected cells. During the late stages of infection, vRNPs must be exported from the nucleus to the cytoplasm prior to transport to viral assembly sites on the cellular plasma membrane. Previously, we demonstrated that the influenza A virus nuclear export protein (
NEP
, formerly referred to as the NS2 protein) mediates the export of vRNPs. In this report, we suggest that for influenza B and C viruses the nuclear export function is also performed by the orthologous
NEP
proteins (formerly referred to as the NS2 protein). The influenza virus B and C
NEP
proteins interact in the yeast two-hybrid assay with a subset of nucleoporins and with the Crm1 nuclear export factor and can functionally replace the effector domain from the human immunodeficiency virus type 1 Rev protein. We established a plasmid transfection system for the generation of virus-like particles (VLPs) in which a functional viral RNA-like
chloramphenicol acetyltransferase
(
CAT
) gene is delivered to a new cell. VLPs generated in the absence of the influenza B virus
NEP
protein were unable to transfer the viral RNA-like
CAT
gene to a new cell. From these data, we suggest that the nuclear export of the influenza B and C vRNPs are mediated through interaction between
NEP
proteins and the cellular nucleocytoplasmic export machinery.
...
PMID:Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. 1146 9